BEVACIZUMAB相关论文
新生血管性青光眼（neovascular glaucoma, NVG）是一种导致视力破坏的严重青光眼,它是由新生血管破坏房水外流通道引起,通常继发于眼......
Equivalent efficacy assessment of QL1101 and bevacizumab in nonsquamous non-small cell lung cancer p
Objective:Anti-vascular endothelial growth factor(VEGF)monoclonal antibodies are an effective means of treating non-smal......
Until recently,docetaxel-based therapy represented the only therapy shown to prolong survival in patients with metastati......
...
The efficacy and safety of irinotecan ± bevacizumab and oxaliplatin ± bevacizumab in metastatic colo
Objective Background: Irinotecan-based and oxaliplatin-based regimens are available for the treatment of metastatic colo......
Risk of fatal adverse events associated with bevacizumab,cetuximab,and panitumumab in 25,000 patient
Objective The present meta-analysis was conducted to evaluate the fatal adverse events(FAEs)of targeted drugs including ......
Vascular normalized therapy by targeting vessel regional bevacizumab infusion in hepatocellular carc
...
Bevacizumab:Is it an optimal first-line therapeutic drug for right-sided metastatic colorectal cance
Objective The effect of tumor laterality in anti-vascular endothelial growth factor antibody and which kind of targeted ......
目的 目前对于复发脑转移瘤的最佳治疗方案尚存争议。近期研究表明分次立体定向放射外科治疗(FSRS)作为挽救性方案，治疗复发的大体......
The efficacy and safety of irinotecan ± bevacizumab compared with oxaliplatin ± bevacizumab for meta
...
目的 To observe the efficacy of local application of bevacizumab for patients with malignant pleural effusion or ascites......
目的 探讨Temozolomide(TMZ)和Bevacizumab(BEV)对裸小鼠原位胶质母细胞瘤微血管新生方式及DCE-MRI特征的影响，为胶质母细胞瘤抗血......
First-line pemetrexed/carboplatin or cisplatin/bevacizumab compared with paclitaxel/carboplatin/beva
Objective Background The study was conducted to compare the effectiveness and safety of pemetrexed/carboplatin or cispla......
Anlotinib abolishes lung adenocarcinoma potential metastasis induced by bevacizumab via down-regulat
目的 We found that bevacizumab facilitated migration and invasion of lung adenocarcinoma under higher concentration of b......
Objective Background Platinum-based chemotherapy can significantly prolong the survival period of non-squamous non-small......
The clinical observation of Bevacizumab combined chemotherapy to treat persistent and/or recurrent u
Objective: To observe the therapeutic effect of Bevacizumab (BEV) combined chemotherapy to treat persistent and/or recur......
Background:Anti-VEGF therapy (intravitreous bevacizumab) is a rational approach to treating retinal or choroidal neovasc......
Background:Bevacizumab (BEV) is increasingly being used combined with neoadjuvantchemoradiation in patients with locally......
The Relationship between Anti-Vascular Endothelial Growth Factor and Fibrosis in Proliferative Retin
Purpose To investigate the progression of retinal fibrosis after intravitreal bevacizumab injection(IVB)therapy in patie......
Bevacizumab plus cisplatin and helical tomotherapy in treatment of locally advanced nasopharyngeal c
Background: In recent years, chemotherapy, radiotherapy, and targeted drugs have been respectively used in nasopharyngea......
Bevacizumab alone and in combination with Irinotecan in recurrent glioblastoma multiforme: A meta-an
The combination of Bevacizumab and Irinotecan is a new chemotherapy for recurrent glioblastoma multiforme (GBM).Recent p......
目的：结肠癌的发病率在我国逐年升高,Bevacizumab一定程度改善了晚期结直肠癌的预后,但疗效远低于预期。自噬作为肿瘤的一种自我保......
会议
The prognostic and predictive value of carbohydrate antigen 19-9 in metastatic colorectal cancer pat
Objective: We had previously demonstrated that the carbohydrate antigen 19-9(CA19-9),lactate dehydrogenase(LDH),neutroph......
Background: Tumor vessels supported by pericytes were considered to be responsible for the failure of some anti-angiogen......
Objective This retrospective study investigated the efficacy and safety of bevacizumab treatment for refractory brain ed......
A 40-year-old Chinese female patient with radiation-induced brain necrosis after radiosurgery was treated with bevacizum......
Comparison of bevacizumab with cetuximab as the first? line bio? chemotherapy for patients with meta
The present observational cohort study was designed to elucidate the efficacy and safety profile of bevacizumab or cetux......
The mechanism of bevacizumab combined with cisplatin interfer the invasion and metastasis of lung ad
Objective: Research on the mechanism of bevacizumab combined with cisplatin inhibits the invasion and metastasis of Lewi......
Objective: Summary of the latest progress of bevacizumab combined with chemotherapy in the treatment of lung cancer in r......
Efficacy and security of treatment by bevacizumab and platinum-based on chemotherapy on advanced non
Objective: To evaluate efficacy and security of treatment by bevacizumab and platinum on advanced nonsmall-cell lung can......
A novel pharmacokinetic model based on the complex elimination of monoclonal antibodies for bevacizu
Background and Purpose: The complex pharmacokinetic (PK) properties of monoclonal antibody (mAb) including a nonlinear p......
Objective: To evaluate the optimal timing of bevacizumab (BEV) therapy in patients with glioblastoma (GBM).Methods: A to......
青光眼是一组以特征性视神经损害和视野缺损为特点的眼病，病理性眼压增高是其主要危险因素，目前的治疗策略主要包括药物控制眼压和手......
...
Inhibition of neovascularization and expression shift of pro-/anti-angiogenic vascular endothelial g
...
Intravitreal bevacizumab with or without triamcinolone acetonide for diabetic macular edema: a meta-
...
Progress of anti-vascular endothelial growth factor therapy for ocular neovascular disease: benefits
...
Efficacy and safety of first-line chemotherapy plus bevacizumab in patients with metastatic colorect
...
目的 观察玻璃体腔注射Bevacizumab,小梁切除联合玻璃体切除治疗新生血管性青光眼临床疗效.方法 对19例19只眼药物不能控制的新生......
黄斑水肿是视网膜静脉阻塞(RVO)的严重并发症,血管内皮生长因子(VEGF)在黄斑水肿发病中起重要作用.目前的临床研究证实,玻璃体内注......
Bevacizumab是重组人VEGF单克隆抗体,继治疗湿性年龄相关性黄斑变性取得初步肯定的效果以来,其在眼内其他新生血管疾病应用的临床......
目的 观察玻璃体腔内注射Bevacizumab(Avastin)治疗湿性年龄相关性黄斑变性(ARMD)术后各时间段的视野变化情况.方法 采用单中心随......
期刊
目的 探讨玻璃体腔注射Bevacizumab (IVB)联合小梁切除术、全视网膜光凝(PRP)治疗新生血管性青光眼(NVG)的长期疗效.方法 回顾性系......
Atezolizumab and bevacizumab as first line therapy in advanced hepatocellular carcinoma:Practical co
Hepatocellular carcinoma(HCC)is the most common primary liver cancer.For advanced HCC,sorafenib was considered the stand......
